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Dehydroepiandrosterone (DHEA) and its sulfate conjugate (DHEA-S) are the most abundantly produced human
adrenal steroids to be reduced with age. DHEA may be related to the process of skin aging through the regulation
and degradation of extracelluar matrix protein. In this study, we demonstrate that DHEA can increase procollagen
synthesis and inhibit collagen degradation by decreasing matrix metalloproteinases (MMP)-1 synthesis and in-
creasing tisuue inhibitor of matrix metalloprotease (TIMP-1) production in cultured dermal ﬁbroblasts. DHEA was
found to inhibit ultraviolet (UV)-induced MMP-1 production and the UV-induced decrease of procollagen synthesis,
probably due to the inhibition of UV-induced AP-1 activity. DHEA (5%) in ethanol:olive oil (1:2) was topically applied
to buttock skin of volunteers 12 times over 4 weeks, and was found to significantly increase the expression of
procollagen a1(I) mRNA and protein in both aged and young skin. On the other hand, topical DHEA significantly
decreased the basal expression of MMP-1 mRNA and protein, but increased the expression of TIMP-1 protein in
aged skin. We also found that DHEA induced the expressions of transforming growth factor-b1 and connective
tissue growth factor mRNA in cultured ﬁbroblasts and aged skin, which may play a role in the DHEA-induced
changes of procollagen and MMP-1 expression. Our results suggest the possibility of using DHEA as an anti-skin
aging agent.
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Despite being the most abundant steroid in the circulation in
men and women, the physiological roles of dehydroepiand-
rosterone (DHEA) and its sulfate (DHEA-S) are little under-
stood (Labrie et al, 1997; Hinson and Raven, 1999). In fact,
although the ovaries or testes are the exclusive sources of
androgens and estrogens in lower mammals, man and
some other primates are unique in having adrenals that se-
crete large amounts of the precursor steroids DHEA-S and
DHEA, which are converted initially into androstenedione
and then into potent androgens and/or estrogens in pe-
ripheral tissues (Labrie, 1991). These locally produced an-
drogens and/or estrogens exert their action in the cells in
which they are synthesized, without being released into the
extracellular space.
The levels of plasma DHEA and DHEA-S are influenced
by age, physiological status, and genetics (Hinson and
Raven, 1999), and most of the DHEA circulating in blood is
in the sulfated form (DHEA-S). DHEA and DHEA-S appear to
be freely interconvertible by extra-adrenal sulfotransferase
and sulfatase activity (Arlt et al, 1998) The secretion of
DHEA and DHEA-S by the adrenals increases progressively
during adrenarche in both boys and girls, and maximal val-
ues are reached between the ages of 20 and 30 y. There-
after, they decrease markedly to only 20% of their peak
values by the age of 70 y, and then further decrease to only
5% by the age of 85–90 y (Orentreich et al, 1984; Belanger
et al, 1994; Hinson and Raven, 1999).
The decrease in the serum levels of DHEA and DHEA-S
during aging results in a reduction in the formation of potent
androgens and estrogens in peripheral tissues, which is
thought to be involved in the pathogenesis of some age-
related conditions (Belanger et al, 1994). Recent interest in
DHEA stems from its beneficial effects on atherosclerosis
(Nestler et al, 1992), the lipid metabolism (Clore, 1995), os-
teoporosis (Sun et al, 2002), diabetes (Coleman et al, 1984),
and skin aging (Baulieu et al, 2000). But the supplementa-
tion of DHEA to prevent or treat these disease is contro-
versial, since hepatomegaly, hepatic tumors, androgenicity,
and insulin resistance have been reported in DHEA-treated
rodents (Tagliaferro et al, 1986; Berdanier and McIntosh,
1989).
The skin aging process can be divided into intrinsic aging
and photoaging. Clinically, naturally aged skin is smooth,
pale, and finely wrinkled. In contrast, photoaged skin is
coarsely wrinkled and associated with dyspigmentation and
telangiectaisa (Gilchrest, 1989). Alterations in collagen, the
major structural component of skin, have been suggested1These authors contributed equally to this work.
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to be causes of clinical changes, such as the skin wrinkling
and the loss of elasticity, observed in naturally aged and
photoaged skin (Fisher et al, 1997; Varani et al, 2000). With
increasing age, collagen synthesis reduces and matrix met-
alloproteinases (MMP) levels are elevated in sun-protected
human skin (Varani et al, 2000; Chung et al, 2001). This
collagen deficiency due to natural skin aging may arise from
its reduced synthesis with increased degradation with a
concomitant elevation of MMP expression. Ultraviolet irra-
diation (UVR) induces the synthesis of MMP in human skin
in vivo, and MMP-mediated collagen destruction accounts,
in large part, for the connective tissue damage that occurs
in photoaging (Fisher et al, 1996, 1997). Therefore, it is be-
lieved that the restoration of the collagen deficiency in aged
human skin by the induction of new collagen synthesis and
by the reduction of MMP, presents a possible strategy for
treating and preventing the clinical manifestations of skin
aging, namely, wrinkles and skin laxity.
It was recently demonstrated that the oral administration
of DHEA for a year improved skin status in the elderly, par-
ticularly in woman, in terms of hydration, epidermal thick-
ness, sebum production, and pigmentation. (Baulieu et al,
2000). When administered topically, as a skin cream, to
healthy postmenopausal women, vaginal epithelium matu-
ration was stimulated and bone mineral density was signif-
icantly increased (Labrie et al, 1997). Therefore, topical
DHEA may be a useful form of hormone replacement ther-
apy in postmenopausal women, because it has estrogenic
effects on the vaginal epithelium without the unwanted en-
dometrial actions of estrogen HRT, and because it exerts an
androgenic effect by stimulating bone formation (Labrie
et al, 1997). Moreover, DHEA and DHEA-S are known to be
involved in the regulation of collagen and MMP production
(Sakyo et al, 1986; Yoshida et al, 1993; Lee et al, 2000).
The effects of DHEA on the collagen metabolism in hu-
man skin, however, have not been well investigated. In this
study, we demonstrated that DHEA increased the expres-
sion of type I procollagen and tisuue inhibitor of matrix me-
talloprotease (TIMP-1), and decreased MMP-1 expression
in human skin in vivo and in cultured fibroblasts, and DHEA
induced transforming growth factor-b1 (TGF-b1) and con-
nective tissue growth factor (CTGF) mRNA expressions in
aged skin, which may play an important role in stimulating
procollagen synthesis.
Results
Effects of DHEA on the expressions of type I procolla-
gen, MMP-1, and TIMP-1 in cultured human dermal
ﬁbroblasts We studied the effects of DHEA on the expres-
sions of type I procollagen, MMP-1, and TIMP-1 proteins in
cultured human dermal fibroblasts. Human dermal fibro-
blasts were treated with 10 mM DHEA for 24, 48, and 72 h,
and the expression levels of these proteins were determined
in the culture media by western blot. We found that DHEA
increased the expression of type I procollagen and TIMP-1
protein, and decreased MMP-1 protein maximally at 72 h
post-treatment (data not shown). Human dermal fibroblasts
were then treated with various doses of DHEA for 72 h to
investigate its concentration-dependent effects. DHEA sig-
nificantly increased type I procollagen protein expression
(Fig 1a), and concentration-dependently decreased MMP-1
protein expression, versus the vehicle-treated controls
(Fig 1b). The expression of TIMP-1 protein was increased
in a concentration-dependent manner, compared with the
non-DHEA-treated controls (Fig 1c).
DHEA prevented UV-induced changes of MMP-1 and type
I procollagen expression and inhibited UV-induced AP-1
binding activity in human dermal ﬁbroblasts Previously
Figure1
The effects of dehydroepiandrosterone (DHEA) on the expressions
of type I procollagen, matrix metalloprotease (MMP)-1, tissue in-
hibitor of metalloprotease (TIMP)-1 proteins in human dermal fib-
roblasts. Human dermal fibroblast cultures were treated with 10, 50,
and 100 mM DHEA for 72 h. The expression levels of (a) type I pro-
collagen, (b) MMP-1, and (c) TIMP-1 were analyzed by western blotting,
as described in ‘‘Material and Methods’’. Results shown are mean-
s  SEM. n¼ 5, po0.05, po0.01.
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it has been shown that UVR decreases procollagen syn-
thesis (Fisher et al, 2000) and induces the synthesis of MMP,
such as MMP-1, MMP-3, and MMP-9, in human skin in vivo
(Fisher et al, 1997). To determine whether DHEA has any
inhibitory effect on the UV-induced changes of procollagen,
MMP-1, and TIMP-1 protein expression, human dermal
fibroblasts were irradiated with 100 mJ per cm2 of UV light
with or without DHEA (10–50 mM) treatment. UVR de-
creased type I procollagen expression (Fig 2a, po0.01,
n¼5) and induced the expression of MMP-1 protein (Fig 2b,
po0.01, n¼ 5). DHEA treatment (50 mM) significantly pre-
vented the down-regulation of type I procollagen by UV. On
the other hand, UV-induced MMP-1 protein expression was
inhibited significantly by DHEA pretreatment (10 mM and
50 mM) (po0.05, n¼5). The expression of TIMP-1 protein
was increased by UV, and pretreatment with DHEA (10 and
50 mM) augmented the UV-induced TIMP-1 expression in
cultured fibroblasts in a concentration-dependent manner
(Fig 2c).
It is known that activated AP-1 stimulates MMP-1 pro-
duction (Fisher et al, 1997), but inhibits type I procollagen
expression transcription (Chung et al, 1996b). Therefore, we
examined whether DHEA has any suppressive effect on UV-
induced AP-1 DNA binding activity in human dermal fibro-
blasts. Cultured fibroblasts were irradiated with 100 mJ per
cm2 of UV light, and DHEA (10, 50, and 100 mM) was treated
immediately after this irradiation for 12 h. UVR induced AP-1
binding activity, and DHEA inhibited this UV-induced AP-1
DNA binding activity concentration-dependently (Fig 2d ).
The topical application of DHEA increased the expres-
sions of type I procollagen mRNA and protein in human
skin in vivo To investigate whether DHEA affects collagen
metabolism in human skin in vivo, as it does in cultured
fibroblasts, the buttock skins of young and aged volunteers
were treated with 5% DHEA solution three times per week
for 4 wk under occlusion. Vehicle (ethanol:olive oil (1:2))-
treated skin served as a control. Using in situ hybridization
(Fig 3a) and immunohistochemical staining (Fig 3b), we
found that topical DHEA treatment increased the expression
of type I procollagen mRNA (Fig 3a) and protein (Fig 3b)
significantly in both aged (n¼6) and young (n¼5) skin
in vivo. These results were confirmed by RT-PCR using
total RNA isolated from the biopsied skin samples and by
Figure 2
Dehydroepiandrosterone (DHEA) prevented UV-induced expression of matrix metalloprotease (MMP)-1 and type I procollagen, and AP-1
binding activity in cultured human dermal fibroblasts. Cultured fibroblast cells were exposed to 100 mJ per cm2 of UV irradiation, as described in
‘‘Material and Methods’’. After UV irradiation, cells were treated with 10 or 50 mM DHEA for 72 h. The expression levels of (a) type I procollagen
(n¼ 5), (b) MMP-1 (n¼ 5), and (c) tissue inhibitor of metalloprotease (TIMP)-1 (n¼4) were analyzed by western blotting. Results shown are
means  SEM. po0.05, po0.01, vehicle versus UV irradiation. ypo0.05, UV irradiation versus DHEA treated groups. (d) After UV irradiation,
cells were treated with 10, 50, or 100 mM DHEA for 12 h. AP-1 binding activity was analyzed by electrophoretic mobility shift assays. The photograph
is representative of three identical experiments. NS, non-specific binding.
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Figure 3
Topical application of dehydroepiandrosterone (DHEA) increases the expression of type I procollagen mRNA and protein in human
skin in vivo. 5% DHEA or its vehicle (ethanol:olive oil (1:2)) were applied to the buttock skin 12 times for 4 wk under occlusion. (a) The expression
of type I procollagen mRNA in the dermis of aged (n¼ 6) and young (n¼ 5) skin was detected by in situ hybridization. Areas in boxes are shown
as 2.5-fold enlargements. (b) The expression of type I procollagen protein in the dermis was detected by immunohistochemical staining in aged
(n¼ 6) and young (n¼5) skin. (c) The expressions of type I procollagen and glyceraldehyde-3-phosphate dehydrogenase mRNA were measured
in total RNA extracted from skin samples of the control and DHEA-treated subjects, respectively, by RT-PCR. The photographs are representative
of aged (n¼ 4) and young (n¼5) subjects, respectively. The results shown are means  SEM. po0.05, po0.01. (d) The expression of
type I procollagen protein was measured in soluble proteins extracted from the dermis of the control and DHEA-treated subjects, respectively, by
western blotting. The photographs are representative of aged (n¼ 5) and young (n¼ 5) DHEA-treated subjects. Results shown are means  SEM.
po0.05.
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western blotting using the soluble protein fraction extracted
from the dermis. Topical application of DHEA significantly
increased the expression of procollagen a1(I) mRNA in aged
(n¼ 4, po0.01) and young skin (n¼5, po0.05), compared
with vehicle-treated control skin (Fig 3c). The expression of
type I procollagen protein was also increased in the DHEA-
treated aged (n¼5, po0.05) and young (n¼5, po0.05)
skin compared with the vehicle-treated control (Fig 3d ).
The topical application of DHEA reduced the expres-
sions of MMP-1 mRNA and protein and increased the
expression of TIMP-1 protein in human skin in vivo To
investigate the effects of DHEA on the expression of MMP-1
mRNA in human skin in vivo, RT-PCR analysis was per-
formed using total RNA isolated from the biopsied skin
samples of elderly volunteers. Topical DHEA treatment
significantly reduced MMP-1 mRNA expression (n¼5,
po0.01), compared with the vehicle-treated skin (Fig 4a).
By western blot analysis, we found that the topical appli-
cation of DHEA reduced the MMP-1 protein level in
the epidermis (n¼ 4, po0.05) versus vehicle-treated skin
(Fig 4b). On the other hand, MMP-1 protein bands in the
dermal extracts were too faint to be detected by western blot.
We demonstrated that topical DHEA treatment did not
significantly change the TIMP-1 mRNA expression (n¼5,
Fig 4c), by RT_PCR using total RNA isolated from punch-
biopsied skin samples of elderly volunteers. The topical
application of DHEA, however, significantly increased the
expression of TIMP-1 protein (n¼6, po0.01) in the dermis,
versus vehicle-treated skin (Fig 4d ). TIMP-1 protein ex-
pression was not detectable in epidermal extracts (data not
shown).
DHEA increased the expressions of TGF-b1 and CTGF
mRNA in cultured human dermal ﬁbroblasts and human
skin in vivo To understand the mechanism of the DHEA-
induced upregulation of procollagen expression, we inves-
tigated the effects of DHEA on the expressions of TGF-b1
and CTGF mRNA in cultured human dermal fibroblasts and
human skin in vivo. RT-PCR analysis, using total RNA iso-
lated from the fibroblast, showed that DHEA (10 mM) treat-
ment significantly increased TGF-b1 mRNA level (n¼3,
Figure 4
Topical application of dehydroepiandrosterone (DHEA) decreases the matrix metalloproteinase (MMP)-1 expression and increases the
expression of tissue inhibitor of metalloprotease (TIMP)-1 protein in human skin in vivo. The expressions of (a) MMP-1, (c) TIMP-1 mRNA were
analyzed by RT-PCR, as described in ‘‘Material and Methods’’. The photographs are representative of five controls and five DHEA-treated subjects.
(b) The expression of MMP-1 protein was measured in soluble proteins extracted from the epidermis of control and DHEA-treated subjects, by
western blotting. The photographs are representative of four control and four DHEA-treated subjects. (d) The expression of TIMP-1 protein was
measured in soluble proteins extracted from the dermis of control and DHEA-treated subjects, by western blotting. The photographs are rep-
resentative of six control and six DHEA-treated subjects. Results shown are means  SEM. po0.05, po0.01.
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po0.05) at 24 h post-treatment (Fig 5a), and CTGF mRNA
expression (n¼3, po0.05) at 48 h post-treatment (Fig 5b).
By using total RNA isolated from the biopsied skin samples,
we also demonstrated that DHEA treatment significantly
increased TGF-b1 and CTGF mRNA level (n¼4, po0.05) in
human skin in vivo (Fig 5c).
Discussion
Alterations in collagen, the major structural component of
skin, have been suggested to be a cause of the clinical
changes observed in photoaged and naturally aged skin
(Fisher et al, 1997; Varani et al, 2000). The dermis contains
predominantly type I collagen (85%–90%) with lesser
amounts of type III collagen (10%–15%). Dermal fibroblasts
synthesize the individual polypeptide chains of types I and
III collagen as precursor molecules called procollagen.
Fisher et al (1996, 1997) showed that UV irradiation induces
the synthesis of MMP in human skin in vivo. Moreover,
MMP-mediated collagen destruction accounts for a large
part of the connective tissue damage that occurs in pho-
toaged skin. Recently, it was suggested that collagen
damage might occur during natural skin aging, as it does
in photoaging, from elevated MMP expression and a con-
comitant reduction in collagen synthesis. Varani et al (2000)
reported that with increasing age, MMP levels become
higher and collagen synthesis lower in sun-protected hu-
man skin in vivo.
In this study, we found that DHEA can increase the
procollagen synthesis and inhibit collagen degradation by
decreasing MMP-1 synthesis and increasing TIMP-1 pro-
duction in cultured dermal fibroblasts. Several studies have
reported the effects of DHEA on the regulation of collagen
and MMP gene expressions, and some discrepancies exist
among these reports. DHEA increased human a1 (I) pro-
collagen and reduced collagenase (MMP-1) gene expres-
sion in cultured skin fibroblasts (Lee et al, 2000). In human
cultured chondrocytes, DHEA increased type II collagen
and TIMP-1 gene expressions, but decreased type I colla-
gen, MMP-1, and MMP-3 expression (Jo et al, 2003). On the
other hand, DHEA-S stimulated collagenase and gelatinase
production, but did not alter collagen production in rabbit
cervical tissue (Sakyo et al, 1987). It has also been reported
that DHEA-S increases the collagenase activity of cervical
fibroblasts in rabbits, whereas DHEA does not (Sakyo et al,
1986). This result suggests that the stimulatory effect of
DHEA-S on the production of collagenase and gelatinase is
due to unchanged DHEA-S, and not to DHEA converted
from DHEA-S (Sakyo et al, 1986). In this study, the DHEA
treatment of cultured human dermal fibroblasts increased
type I procollagen protein expression significantly and
reduced the production of MMP-1 protein in a concentra-
tion-dependent manner. DHEA also significantly increased
the production of TIMP-1 protein in a concentration-de-
pendent manner. These results indicate that DHEA plays an
important role in the regulation of the production and deg-
radation of the extracellular matrix. Differences between our
results and those of other studies may be due to tissue-
and/or species-specific DHEA effects, the different biolog-
ical effects of DHEA-S and DHEA, and the concentration of
DHEA used in the studies.
We also found that DHEA can prevent the UV-induced
increase of MMP-1, and the UV-induced decrease of
Figure 5
Dehydroepiandrosterone (DHEA) increased the expressions of
transforming growth factor-b1 (TGF-b1) and connective tissue
growth factor (CTGF) mRNA in cultured fibroblasts and aged hu-
man skin in vivo. Human dermal fibroblast cultures (n¼3) were treated
with 10, 50, and 100 mM DHEA for 24 and 48 h. The expression levels of
(a) TGF-b1 mRNA and (b) CTGF mRNA were analyzed by RT-PCR, as
described in ‘‘Material and Methods’’. (c) The expressions of TGF-b1,
CTGF, and GAPDH mRNA in aged human skin (n¼4) were analyzed by
RT-PCR. The photographs are representative of four control and four
DHEA-treated subjects. Results shown are means  SEM. po0.05.
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procollagen production in cultured dermal fibroblasts.
Therefore, our results strongly suggest the possibility that
DHEA is a candidate agent for the prevention and treatment
of clinical changes, such as the skin wrinkles and laxity,
which typify photoaged and naturally aged skins. Upon the
UV irradiation of human skin, c-fos protein heterodimerizes
with UV-induced c-jun, and forms an active form of the
transcription factor AP-1. This UV-activated AP-1 stimulates
the transcription of MMP gene encoding collagenase, 92
kDa gelatinase, and stromelysin-1 in both keratinocytes and
fibroblasts (Fisher et al, 1996, 1997) These UV-induced
MMPs degrade collagen and other components in the der-
mal exracellular matrix in human skin. With each intermittent
UV exposure, MMP-mediated dermal damage accumu-
lates, and damages the structural integrity of the dermis.
Eventually this process manifests itself as clinically observ-
able solar scars (i.e., wrinkles) in chronically photodamaged
skin (Fisher et al, 1997). In addition, AP-1 is also known to
regulate type I procollagen gene expression negatively
(Chung et al, 1996b). In this study, we found that DHEA
prevents UV-induced AP-1 DNA binding activity concen-
tration-dependently in cultured dermal fibroblasts. There-
fore, DHEA can inhibit UV-induced MMP-1 production and
procollagen synthesis, probably by inhibiting UV-induced
AP-1 activity. It has been reported that AP-1 stimulates
TIMP-1 gene expression (Smart et al, 2001; Hall et al, 2003).
In this study, however, DHEA augmented UV-induced TIMP-
1 up-regulation, even though DHEA inhibited UV-induced
AP-1 activity. These results suggest that DHEA increases
the expression of TIMP-1 through an AP-1-independent
pathway.
We found that topically applied 5% DHEA on aged hu-
man skin in vivo significantly increased the expression of
procollagen a1 (I) mRNA and protein. On the other hand, it
reduced the basal expressions of MMP-1 mRNA and pro-
tein significantly, and increased the expressions of TIMP-1
protein in aged skin. It is well known that TGF-b potently
stimulates collagen synthesis, and it has been demonstrat-
ed that TGF-b decreases MMP-1 expression and increases
TIMP-1 (Edwards et al, 1996; Eickelberg et al, 1999; Hall
et al, 2003). CTGF is constitutively expressed in normal hu-
man skin in vivo, and in normal human skin keratinocytes
and fibroblasts (Quan et al, 2002). Moreover, CTGF expres-
sion is rapidly induced by TGF-b in skin fibroblasts, and
accumulating evidence indicates that the inductive effects
of TGF-b on procollagen production are mediated by CTGF
(Grotendorst, 1997; Duncan et al, 1999; Quan et al, 2002).
CTGF also stimulated procollagen production when injected
into mouse skin or when added to fibroblast culture (Dun-
can et al, 1999). In this study, we found that DHEA signif-
icantly increased the expressions of TGF-b1 and CTGF
mRNA in cultured human fibroblast and aged human skin
in vivo. These results suggest that DHEA-induced TGF-b1
may be involved in the induction of procollagen and TIMP-1
expression and in the inhibition of MMP-1 expression in
cultured human fibroblast and aged human skin in vivo.
DHEA may stimulate procollagen synthesis in aged human
skin by inducing CTGF by increasing TGF-b1 expression.
To our knowledge, this is a report regarding the effects of
topical DHEA on collagen metabolism in aged human skin
in vivo.
DHEA is a multifunctional hormone with beneficial ef-
fects, which include an anti-aging effect (Yen, 2001). The
adrenal glands of humans synthesize and secrete large
amounts of DHEA and DHEA-S that are biotransformed into
biologically active androgens and estrogens in peripheral
tissues. It is estimated that more than 30% of total andro-
gen in men and over 90% of estrogen in postmenopausal
women are derived from the peripheral conversion of
DHEA/DHEA-S (Labrie et al, 1995). Thus, the intracellular
biotransformation of DHEA to active sex steroids may allow
local binding to their specific intracellular nuclear receptors
with minimal loss in terms of concentration and time, to
exert maximal functional effect (Labrie et al, 1995). In this
study, the observed effects of DHEA on collagen metabo-
lism in aged human skin may have been the result of DHEA
androgenic or estrogenic action. It has been suggested that
the potent stimulatory effect of DHEA on bone formation in
ovariectomized rats is mainly due to the local formation of
androgens in bone cells, because it was inhibited by anti-
androgen treatment but not by antiestrogen treatment
(Martel et al, 1998). Further investigation is necessary to
understand the molecular mechanisms of the hormonal ef-
fects of DHEA on collagen metabolism in aged human skin.
In conclusion, we propose that DHEA has the potential to
be used topically for the treatment and prevention of skin
aging processes, based on the following; (1) DHEA stimu-
lates procollagen and TIMP-1 protein production and de-
creases MMP-1 expression in cultured fibroblasts. (2) DHEA
prevents UV-induced changes of MMP-1 and procollagen
expression by inhibiting UV-induced AP-1 activation. (3) The
topical application of DHEA in aged human skin increases
procollagen and TIMP-1 levels and reduces MMP-1 ex-
pression. (4) Topical application of DHEA increases TGF-b1
and CTGF expression to induce procollagen synthesis in
aged skin.
Materials and Methods
Fibroblast cell culture Primary cultures of dermal fibroblasts
were established from human adult foreskins in Dulbecco’s mod-
ified eagle medium (DMEM) supplemented with 10% fetal calf se-
rum, 2 mM glutamine, penicillin (100 U per mL), and streptomycin
(100 mg per mL) in a 371C humidified 5% CO2 incubator. Ascorbic
acid was not added in the culture media, and fibroblasts cultured in
this culture media could synthesize collagen normally as observed
previously (Chung et al, 1996a, 1997). The fibroblasts were cul-
tured until 90% confluent and then subcultivated. Cells cultured
4five passages were used for the experiments.
Human skin samples A total of six elderly Koreans (six men;
mean age, 80 y; age range, 75–87 y) and five young Koreans (five
men; mean age, 23 y; age range, 22–24 y), without current or prior
skin disease, provided skin samples. To observe the effects of the
topical application of DHEA, a 5% DHEA solution and its vehicle
(ethanol:olive oil (1:2)) were applied to the buttock skin (3  3 cm)
12 times over 4 wk under occlusion. DHEA treatment did not
change the serum levels of DHEA, DHEA-S, and testosterone (data
not shown). Skin samples were then obtained from the subjects by
punch biopsy, as previously described (Seo et al, 2001). This study
was conducted according to the Declaration of Helsinki Principles.
All procedures involving human subjects received prior approval
from the Seoul National University Institutional Review Board, and
all subjects provided written informed consent.
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To separate epidermis from dermis, a defrosted whole skin
sample was placed dermis-side down on a Petri dish, heated at
551C for 2 min, and then separated gently with a forceps. The
separated epidermis and dermis were then frozen in liquid nitrogen
and stored at 801C until use.
UVR The UV light source was an F75/85W/UV21 fluorescent sun
lamp, with an emission spectrum between 285 and 350 nm (peak
at 310–315 nm), as previously described (Chung et al, 2003). A
Kodacel filter (TA401/407; Kodak, Rochester, New York) was
mounted 2 cm in front of the UV tubes to remove wavelengths
o290 nm (UVC).
The fibroblasts were grown in 10 cm culture dishes (Falcon,
Lincoln Park, New Jersey) until subconfluent. The cells were then
cultured in serum-free medium for 24 h, the medium was replaced
by 2 mL of phosphate-buffered saline, and the cells were exposed
to UV (0–100 mJ per cm2) light. After this irradiation, the cells were
washed with phosphate-buffered saline, and cultured in DMEM
with or without DHEA for the indicated times.
DHEA DHEA was purchased from Sigma (St Louis, Missouri) and
was used after dissolution either in dimethyl sulfoxide (DMSO) or
ethanol:olive oil (1:2). Cultured fibroblasts were treated with various
doses of DHEA dissolved in DMSO. Elderly volunteers were treated
on buttock skin with 5% DHEA (12 mL per cm2) for 12 times over 4
wk under occlusion. Ethanol:olive oil (1:2) was used as the vehicle.
Western blot analysis Soluble protein fractions were extracted
either from the punch-biopsied skin samples or from cultured fib-
roblasts using WCE buffer (containing 1% Triton X-100, 150 mM
NaCl, 5 mM ethylenediamine tetraacetic acid, 0.1 mM dithio-
threitol, 1 mM PMSF, 1 mg per mL aprotinin, and 2 mg per mL
leupeptin). Lysates were centrifuged at 12,000  g for 10 min, and
the supernatant thus obtained was used for Western blot analysis,
as described previously (Chung et al, 2001). A monoclonal anti-a1
(I) procollagen aminoterminal extension peptide (SP1.D8) antibody
(Developmental Studies Hybridoma Bank, Iowa City, Iowa), a
monoclonal anti-MMP-1 antibody (Oncogen, Boston, Massachu-
setts), and a polyclonal anti-TIMP-1 antibody (Santa Cruz Bio-
technology, Santa Cruz, California) were used as primary
antibodies.
Electrophoretic mobility shift assays (EMSA) EMSA were per-
formed using a commercial kit, according to the manufacturer’s
instructions (Promega, Madison, Wisconsin). Briefly, AP-1 (50-CGC
TTG ATG CAG CCG GAA-30) consensus oligonucleotides were 32P
end labeled by incubation for 10 min at 371C with 10 U T4 po-
lynucleotide kinase in a reaction containing 10 mCi (g-32P) ATP
(3000 Ci per mmol at 10 mCi per mL, Amersham Pharmacia,
Piscataway, New Jersey). Fifteen micrograms of the total proteins
were equilibrated for 10 min in a binding buffer (4% glycerol, 1 mM
MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl, 10 mM Tris-HCl
(pH 7.5), and 50 mg per mL poly (dI-dC)). For competition assays, a
cold probe (0.35 pM) was added to the reaction and incubated for
20 min at room temperature. The reaction was stopped, loaded on
a 6% DNA retardation gel (Invitrogen, Carlsbad, California), and run
in 0.5  TBE buffer at 100 V for 120 min. The gel was then dried
and detected by autoradiography.
In situ hybridization The 366 bp XhoI–PvuII frgment of a1 (I) pro-
collagen (corresponding to the coding sequences of a1 (I) procol-
lagen: 3804–4172, GeneBank accession number NM_000088) was
cloned into pCR2.1-TOPO. Digoxigenin-containing sense and
antisense riboprobes detecting human procollagen a1(I) were
synthesized using T7 RNA polymerase. In situ hybridization was
performed on 8 m sections as described previously (Chung et al,
2001). All samples were treated with proteinase K and washed in a
0.1 M triethanolamine buffer conatining 0.25% acetic anhydride.
After hybridization at 521C, the slides were washed under stringent
conditions, and treated with RNase A to remove unhybridized
probe. Hybridization signals were detected immunohistochemical-
ly using an alkaline phosphatase-conjugated anti-digoxigenin
antibody.
Immunohistochemical staining Serial sections of 4-mm thick-
ness from punch biopsy specimens were mounted onto silane
coated slides (Dako, Glostrup, Denmark). Acetone-fixed frozen
sections were stained with monoclonal anti-human procollagen
type I C-peptide (PIC) antibody (Takara, Shiga, Japan), diluted
1:250 overnight at 41C. After rinsing in phosphate-buffered saline,
the sections were visualized using a Histostain-plus kit (Zymed,
San Francisco, California) using a biotinylated secondary antibody
and horseradish–streptavidin conjugate. 3-Amino-9-ethylcarbazole
was used as a chromogenic substrate, and sections were coun-
terstained briefly in Mayer’s hematoxylin. Control staining was
performed with normal rabbit and mouse immunoglobulin, which
showed no immunoreactivity (data not shown).
RT-PCR Total RNA was isolated from either the cultured fibro-
blasts or from biopsied skin samples using Trizol reagent (Life
Technologies, Rockville, Maryland). Isolated RNA samples were
subjected to electrophoresis on 1% agarose gels to assess their
quality and quantity. The extracted total RNA (1 mg) was reverse
transcribed using a first-strand cDNA synthesis kit for RT-PCR
(MBI Fermentas, Hanover, Maryland). The resulting specific cDNA
fragments were amplified with 2.5 U of Taq polymerase (Advanced
Biotechnologies, Surrey, UK) in the presence of 20 pmol down-
stream primer and upstream primer, using three thermocycler
temperatures (1 min at 941C, 1 min at 601C, and 1 min at 721C).
The sequences of specific primers used were as follows: a1 (I)
procollagen (50-CTCGAGGTGGACACCACCCT-30 and 50-CAGCTG
GATGGCCACATCGG-30), corresponding to the coding sequences
of a1 (I) procollagen: 3685–3704 and 4037–4056, respectively
(GeneBank accession number: NM_000088), MMP-1 (50-AT-
TCTACTGATATCGGGGCTTTGA-30 and 50-ATGTCCTTGGGGTATC
CGTGTAG-30), corresponding to the coding sequences of MMP-1:
654–677 and 1069–1091, respectively (GeneBank accession
number: NM_002421), TIMP-1 (50-ATTTCCGACCTCGTCATCA
GG-3 and 50-ACTGGAAGCCCTTTTCAGAGC-30), corresponding
to the coding sequences of TIMP-1: 111–129 and 530–550, re-
spectively (GeneBank accession number: NM_003254), TGF-b1
(50-GCCCTGGACACCAACTATTGC-30 and 50- AGGCTCCAAATG-
TAGGGGCAGG-30), corresponding to the coding sequences of
TGF-b1: 838–858 and 977–998, respectively (GeneBank accession
number: NM_000660), CTGF (50-CCAAGGACCAAACCGTGGT-30
and 50-TACTCCACAGAATTTAGCTCG-30), corresponding to the
coding sequences of CTGF: 506-524 and 838-858, respectively
(GeneBank accession number: NM_001901), and the internal con-
trol glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (50-AT-
TGTTGCCATCAATGACCC-30 and 50-AGTAGAGGCAGGGATGATGT-
30), corresponding to the coding sequences of GAPDH: 88–107
and 614–633, respectively (GeneBank accession number:
BC023632).
Reaction products were subjected to electrophoresis on 2.0%
agarose gel and visualized with ethidium bromide. Signal strengths
were quantified using a densitometric program (TINA; Raytest
Isotopenmebgerate, Staubenhardt, Germany). No PCR products
were obtained in control reactions without reverse transcriptase.
After normalizing versus GAPDH intensity, percentage increase or
decrease was determined. Each experiment was repeated at least
three times.
Statistics Statistical significance was determined using the Student’
t test. Results are presented as means  SEM. All p values quoted
are two-tailed and significance was accepted when p was o0.05.
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